OMICRON XBB.1.16-ADAPTED VACCINE FOR COVID-19: INTERIM IMMUNOGENICITY AND SAFETY CLINICAL TRIAL RESULTS

(1) Background: The global coronavirus disease 2019 vaccination adapts to protect populations from emerging variants.This communication presents interim findings from the new Omicron XBB.1.16-adapted PHH-1V81 protein-based vaccine compared to an XBB.1.5-adapted mRNA vaccine against various acute respiratory syndrome coronavirus 2 (SARS-CoV-2) strai

Contezolid is a novel oxazolidinone, which exhibits potent activity against gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE), and penicillin-resistant Streptococcus pneumoniae (PRSP).In this study, the in vitro activity of contezolid was compared with linezolid (LZD), tige